Sage Journals: Discover world-class research

Abstract

Purpose

The purpose of this study was to identify if any correlation between size of the proximal femoral epiphysis and avascular necrosis (AVN) exists.

Methods

We retrospectively reviewed 111 patients with developmental dysplasia of the hip treated by closed reduction (124 hips). The diameter and height of both femoral head and ossific nucleus were assessed on preoperative MRI.

Results

The diameter and the height of the femoral head as well as of the ossific nucleus of the contralateral side were significantly greater than the dislocated side. AVN occurred in 21 (16.9%) out of 124 hips. The rate of AVN gradually decreased with age: 30.0% at six to 12 months, 18.2% at 12 to 18 months and 3.7% at 18 to 24 months. Spearman correlation analysis showed that age is negatively correlated with the incidence of AVN (r = -0.274; p = 0.002) and the diameter of the femoral head has a significantly negative association with the incidence of AVN (r = -0.287; p = 0.001). No significant association was observed between the incidence of AVN and height of the femoral head or size of the ossific nucleus. Hips with AVN were significantly smaller than hips without AVN.

Conclusions

The size of both the femoral head and the ossific nucleus increase with age although the dislocated femoral head is smaller compared with the contralateral side. The diameter of the femoral head and not the size of the ossific nucleus negatively correlate with the risk of AVN, with a bigger femoral head showing lower risk of AVN.

Level of evidence

III

Keywords

femoral head ossific nucleus developmental dysplasia of the hip closed reduction avascular necrosis

Introduction

Avascular necrosis (AVN) of the proximal femoral epiphysis is a potential complication in children with developmental dysplasia of the hip managed by closed reduction (CR). The goal of treatment is to achieve early, stable reduction of the hip joint and to avoid AVN as it can lead to early degenerative arthritis and/or lower limb length discrepancy, and may ultimately require hip salvage surgery or hip joint replacement.

The reports of AVN in children with developmental dysplasia of the hip (DDH) treated by CR varies between 0% and 67% although its cause remains unknown.^1–6 Age,⁶ high dislocation⁷ and absence of ossific nucleus⁸ have been reported as risk factors for AVN in children with DDH treated by CR.

Although several studies have suggested an association between the presence of the ossific nucleus and a lower rate of AVN in children with DDH treated by closed means, others have raised the concern as to whether its presence truly protects the proximal femoral epiphysis from the occurrence of AVN.^7–15 Moreover, there is a lack of studies investigating the potential association between the size of the proximal femoral epiphysis and the occurrence of AVN.

The aim of this study was to retrospectively evaluate: 1) the size of the proximal femoral epiphysis measured with preoperative MRI in children with DDH treated by CR and spica cast immobilization; and 2) to evaluate the presence of AVN on anteroposterior (AP) pelvis radiographs taken at last follow-up visit. The secondary aim was to identify if any correlation exists between the size of the proximal femoral epiphysis and AVN, the hypothesis being that patients with bigger proximal femur epiphysis have a lower risk of developing AVN.

Materials and methods

After obtaining approval from our institutional review board, we retrospectively reviewed the medical records of 276 patients diagnosed with DDH and treated with CR and cast immobilization at our centre between June 2011 and December 2015.

The inclusion criteria were as follows: 1) diagnosis of DDH; 2) age six to 24 months at initial treatment by CR and spica cast immobilization; 3) complete clinical and radiographic data including preoperative MRI and postoperative AP radiographs; 4) at least 24 months of clinical follow-up.

Exclusion criteria were as follows: 1) concomitant diagnosis of cerebral palsy, arthrogryposis multiplex congentita, myelomeningocele, tethered cord syndrome or other neuromuscular condition; 2) patients older than 24 months at initial treatment; 3) follow-up less than 24 months; 5) incomplete clinical and radiographic data.

A total of 111 out of 276 (40.2%) patients (99 girls, 12 boys; 124 hips) met the inclusion criteria. The left hip was involved in 57 patients (51.4%) and the right hip was involved 41 patients (36.9%); 13 patients had bilateral involvement (11.7%). The mean age at the time of CR was 15.6 months (sd 3.6; 6 to 22.2), and the mean follow-up time was 38.7 months (sd 10.0; 24 to 63).

CR was performed under general anaesthesia in all cases. Arthrogram of the hip joint was performed to evaluate the hip position and to assist reduction. Adductor tenotomy was performed if the adductor was considered an obstacle to CR. After CR, an abduction cast was applied for three months in order to maintain reduction, and it was changed once after six to seven weeks. After cast removal, patients were placed into an abduction brace for an additional six months (three months full-time and three months night-time use only).

Radiographic assessment

All patients were followed up for at least 24 months. MRI was obtained prior to CR in all patients. AP pelvis radiographs in neutral and frog position were obtained prior to CR, immediately after CR and at each follow-up visit. Acetabular index (AI) and centre-edge angle (CEA) was measured on AP pelvis radiographs prior to CR and at last follow-up visit.¹⁶

The severity of hip dislocation was rated according to the Tönnis grading system.¹⁷

AP and frog lateral radiographs taken at last follow-up visit were used to evaluate the primary outcome measure, namely, if AVN was or was not present. AVN of the femoral epiphysis was graded according to method described by Kalamchi-MacEwen.¹⁸ With type I AVN, changes are limited to the femoral head, and the metaphysis was not involved, therefore, type I AVN is thought to represent transient ischemia of the femoral head that can recover completely.¹⁹ Therefore, we grouped type I AVN within the normal hip category.

Final outcome was evaluated with the Severin classification. Severin grades I and II were considered satisfactory outcomes, while Severin grade III and IV were considered unsatisfactory outcomes.²⁰

Two independent raters (WJ and LY) evaluated AVN. If they could not come to an agreement on the type of AVN, a discussion with at least three other senior paediatric orthopaedic surgeons was performed.

Ossific nucleus and size of the proximal femoral epiphysis

All radiographic measurements were performed using standard picture and archiving communication system software (PACS, Beijing, China).

MRI (T2-FFE; Philips, Best, The Netherlands) was used to measure: 1) the diameter of femoral head; 2) the height of femoral head; 3) the diameter of ossific nucleus; 4) the height of ossific nucleus (Fig. 1).

Fig. 1

Measurement of the diameter and height of both femoral head and ossific nucleus on preoperative MRI. The diameter of the femoral head (D) is the distance between two lines tangent to the inner and outer border of the femoral head, and perpendicular to the growth plate of the proximal femoral epiphysis (a). The height of the femoral head (H) is the distance between two parallel lines, one passing through the growth plate of the proximal femur epiphysis, and the second tangent to the top of the femoral head (b). The diameter of the ossific nucleus (d) is the distance between two lines tangent to the inner and outer border of the ossific nucleus, and perpendicular to the growth plate at its bottom (c). The height of the ossific nucleus (h) is the distance between two lines parallel to the growth plate of the proximal femur epiphysis and tangent to the top and the bottom of the ossific nucleus (d).

The diameter of the femoral head (D) is the distance between two lines tangent to the inner and outer border of the femoral head, and perpendicular to the growth plate of the proximal femoral epiphysis (Fig. 1a).

The height of the femoral head (H) is the distance between two parallel lines, one passing through the growth plate of the proximal femur epiphysis, and the second tangent to the top of the femoral head (Fig. 1b).

The diameter of the ossific nucleus (d) is the distance between two lines tangent to the inner and outer border of the ossific nucleus, and perpendicular to the growth plate at its bottom (Fig. 1c).

The height of the ossific nucleus (h) is the distance between two lines parallel to the growth plate of the proximal femur epiphysis and tangent to the top and the bottom of the ossific nucleus (Fig. 1d).

All measurements are expressed in cm.

Statistical analysis

Statistical analysis was performed with SPSS software (version 20.0; SPSS, Chicago, Illinois). Spearman correlation analysis was used to analyze the diameter or height of femoral head or ossific nucleus between age, Tönnis grade, preoperative AI and AVN. The chi squared test, analysis of variance and t-test were used to further confirm the results of Spearman correlation analysis. The tests were two-sided, and a p-value of < 0.05 be significant.

Results

Radiographic measurements showed good to excellent interobserver reliability for AI (intraclass correlation coefficient (ICC) = 0.901), CEA (ICC = 0.843), femoral head height (H) (ICC = 0.919), ossific nucleus height (h) (ICC = 0.928), femoral head diameter (D) (ICC = 0.949) and ossific nucleus diameter (d) (ICC = 0.936).

Among the included 124 hips, three hips (2.4%) were Tönnis grade I, 51 (41.1%) grade II, 66 (53.3%) grade III and 4 (3.2%) were grade IV.

Preoperative mean AI was 35.6° (sd 4.3°; 25° to 44.9°). At the final follow-up, mean AI was 20.7° (sd 5.8°; 3.2° to 37.2°) and mean CEA was 23.7° (sd 9.2°; 0° to 42°). According to Severin classification, 93 hips (75.0%) were grade I, seven (5.7%) grade II, 22 (17.7%) grade III and two2 (1.6%) were grade IV; overall, 100 hips (80.6%; I + II) had satisfactory outcome and 24 hips (19.4%; III + IV) had unsatisfactory outcome.

Femoral head height (H), ossific nucleus height (h), femoral head diameter (D) and ossific nucleus diameter (d) of the unaffected side were significantly greater compared with the dislocated side (p < 0.001) (Table 1).

Table 1

The size (cm) of the femoral head and of the ossific nucleus in patients with developmental dysplasia of the hip

	Normal hip	Dislocated hip	t-value	p-value*
Hips	98	124	−	−
Femoral head, mean (sd)
Diameter	2.27 (0.19)	1.82 (0.26)	21.562	< 0.001
Height	1.33 (0.16)	1.08 (0.18)	12.751	< 0.001
Ossific nucleus, mean (sd)
Diameter	1.01 (0.28)	0.49 (0.28)	25.270	< 0.001
Height	0.68 (0.18)	0.36 (0.20)	22.139	< 0.001

Paired-samples t test

Spearman correlation analysis showed that Femoral head height (H), femoral head diameter (D) and ossific nucleus diameter (d) significantly increased with age (Fig. 2). Femoral head height (H), femoral head diameter (D) and ossific nucleus diameter (d) in patients aged six to 12 months at the time of CR were significantly smaller compared with patients aged 12 to 18 months and 18 to 24 months at the time of index procedure (Table 2).

Fig. 2

Scatter plot of actual measurement of femoral head (FH) or ossific nucleus (ON) diameter or height (cm) by MRI and age (months).

Table 2

Spearman correlation analysis indicates correlation between the size of the ossific nucleus and of the femoral head, age, Tönnis grade and preoperative acetabular index (AI)

	Age		Tönnis grade		Preoperative AI
	Coefficient	p-value*	Coefficient	p-value*	Coefficient	p-value*
Femoral head
Diameter	0.315	< 0.001	-0.220	0.014	0.101	0.266
Height	0.113	0.212	-0.046	0.615	0.020	0.829
Ossific nucleus
Diameter	0.289	0.001	-0.089	0.328	0.048	0.594
Height	0.275	0.002	-0.009	0.925	0.113	0.212

Spearman correlation analysis

Femoral head diameter (D) was negatively correlated with Tönnis grade (r = -0.220; p = 0.014); Tönnis grade I and II hips (1.95 cm (sd 0.33)) hips had significantly greater femoral head diameter (D) compared with grade III and IV hips (1.79 cm (sd 0.21)) (t = 3.048; p = 0.003). There was no significant association between preoperative AI and Femoral head diameter (D), femoral head height (H), ossific nucleus diameter (d) and ossific nucleus height (h) (Table 3).

Table 3

Comparison between the size (cm) of femoral head and the ossific nucleus in dislocated hips among patients of different age (six to 12 months; 12 to 18 months; and 18 to 24 months)

	6 to 12 months	12 to 18 months	18 to 24 months	F-value	ANOVA p-value
Femoral head, mean (sd)
Diameter	1.64 (0.29)	1.89 (0.27)*	1.93 (0.23)**	8.372	0.000
Height	0.98 (0.15)	1.08 (0.12)*	1.13 (0.25)**	4.921	0.009
Ossific nucleus, mean (sd)
Diameter	0.23 (0.28)	0.50 (0.27)*	0.61 (0.22)**	12.145	0.000
Height	0.16 (0.20)	0.37 (0.19)*	0.43 (0.15)**	4.921	0.009

p < 0.05 versus six to 12 months

p > 0.05 versus 12 to 18 months

ANOVA, analysis of variance

In all, 21 out of 124 hips (16.9%) developed AVN, including 12 type II AVN (57.2%), seven type III AVN (33.3%) and two type IV AVN (9.5%). Spearman correlation analysis showed that age is negatively correlated with the incidence of AVN (r = -0.274; p = 0.002). The rate of AVN gradually decreased with age: 30.0% at six to 12 months, 18.2% at 12 to 18 months and 3.7% at 18 to 24 months (p = 0.033).

Spearman correlation analysis showed that the diameter of femoral head has significantly negative association with the incidence of AVN (r = -0.287; p = 0.001). In patients with Tönnis grade I to II dislocation, the diameter of the femoral head was negatively associated with the incidence of AVN (r = -0.453; p = 0.001). Similar results were observed in patients with Tönnis grade III to IV dislocations (r = -0.534; p = 0.001) (Table 4).

Table 4

Subgroup analysis investigating the association between avascular necrosis and the size of the ossific nucleus and of the femoral head in Tönnis grade I to II and grade III to IV hips

	Grade I to II		Grade III to IV
		Coefficient	p-value*	Coefficient	p-value*
Femoral head
Diameter	-0.453	0.001	-0.534	0.001
ΔD%	0.435	0.001	0.026	0.829
Height	-0.112	0.421	-0.166	0.169
ΔH%	0.151	0.274	0.242	0.044
Ossific nucleus
Diameter	-0.241	0.079	-0.073	0.546
Δd%	0.199	0.148	0.046	0.707
Height	-0.198	0.151	-0.087	0.471
Δh%	0.121	0.382	0.084	0.495

ΔD%, the decreased percentage of the diameter of femoral head in dislocated hip related to normal hip; ΔH%, the decreased percentage of the height of femoral head in dislocated hip related to normal hip; Δd%, the decreased percentage of the diameter of ossific nucleus in dislocated hip related to normal hip; Δh%, the decreased percentage of the height of ossific nucleus in dislocated hip related to normal hip

Paired-samples t test

No significant association was observed between the incidence of AVN and Femoral head diameter (D), femoral head height (H), ossific nucleus diameter (d) and ossific nucleus height (h). Femoral head diameter (D) was significantly smaller in patients with AVN (1.69 cm (sd 0.19)) compared with patients without AVN (1.89±0.28 cm); on the other hand, Femoral head height (H), ossific nucleus diameter (d) and ossific nucleus height (h) were similar between patients with or without AVN (p > 0.05) (Table 5).

Table 5

The association between avascular necrosis (AVN) and the size (cm) of the ossific nucleus and of the femoral head in dislocated hips

	Spearman correlation analysis		t-test
	Coefficient	p-value*	No AVN, mean (sd)	AVN, mean (sd)	t	p-value**
Femoral head
Diameter	-0.287	0.001	1.89 (0.28)	1.69 (0.19)	3.133	0.002
ΔD%	0.211	0.019	16.99 (11.12)	22.62 (5.91)	-3.326	0.002
Height	-0.149	0.099	1.09 (0.17)	1.02 (0.12)	1.665	0.099
ΔH%	0.200	0.026	17.77 (11.95)	24.85 (12.02)	-2.473	0.015
Ossific nucleus
Diameter	-0.157	0.082	0.51 (0.29)	0.37 (0.27)	1.942	0.055
Δd%	1.118	0.192	53.09 (24.62)	61.76 (27.99)	-1.436	0.154
Height	-0.139	0.124	0.36 (0.20)	0.28 (0.20)	1.727	0.087
Δh%	0.103	0.256	49.96 (27.25)	58.97 (29.48)	-1.361	0.176

Spearman correlation analysis

Paired-samples t test

In all, 15.2% (16/105) of the hips with an ossific nucleus and 26.3% (5/19) of the hips without an ossific nucleus at the time of CR developed AVN; the AVN rate was not significantly different between the two groups (p = 0.394).

Discussion

This study showed that the size of both the femoral head and of the ossific nucleus increase with age. However, the dislocated side showed a smaller femoral head and ossific nucleus compared with the contralateral side. These findings confirm previous studies. However, none of previously published reports correlated the size of femoral head and the ossific nucleus with occurrence of AVN in children with DDH treated by CR between six and 24 months of age.^21–24

Wanner et al²¹ measured the size of the proximal femoral epiphysis with ultrasound in 37 children with DDH and compared with 75 normal children; they found that the dislocated side was smaller in diameter compared with the contralateral side. Our findings also suggest that the severity of dislocation negatively correlates with the size of the femoral head; in particular, the higher the dislocation, the smaller the proximal femur epiphysis. O'Brien and Salter²² reviewed 103 cases of untreated DDH adult patients, and found that the size of the femoral head of the dislocated side was smaller compared with the unaffected side; they also pointed out that dislocated hips had smaller femoral heads compared with subluxated hips. Similar findings were reported in children by works of Sugano et al²³ and of Crowe et al.²⁴ Therefore, we cannot recommend delaying CR until the femoral head has grown bigger; on the contrary, we suggest timely CR in order to enhance hip joint development thanks to the reciprocal interaction between femoral head and acetabulum.

Several studies have reported that the femoral head is important for promoting the development of the acetabulum regardless of its shape, round or ovoid. In particular, the femoral head with abnormal shape can also affect the development of the acetabulum by inducing progressive morphological modifications.^25,26 Steppacher et al²⁷ and Clohisy et al²⁸ found that the morphological development of the acetabulum is influenced by the shape of the femoral head. Our study shows that the size of femoral head is not significantly associated with preoperative AI.

Moreover, our findings showed no significant correlation between the presence of the ossific nucleus and the occurrence of AVN. However, previously published data are conflicting.^{8–15,29–31} Some authors have suggested that the presence of ossific nucleus at the time of CR is protective against the occurrence of AVN. Carney et al²⁹ reviewed 45 cases (58 hips) of DDH treated by CR and concluded that delaying CR until ossific nucleus would lower the incidence of AVN and hypothesized that the ossific nucleus may add mechanical strength to the femoral head and protect the epiphyseal blood supply from extrinsic compression.^8,32,33 However, most studies indicated that the presence of ossific nucleus did not reduce the rate of AVN (Table 6).^{7,13,15,31,34} Similarly, the meta-analyses by Chen et al,¹¹ Niziol et al¹⁴ and Roposch et al¹⁵ did not find evidence to support the protective effect of the ossific nucleus on the development of AVN, which is consistent with our findings. In addition, our data suggest there is no significant association between the size of ossific nucleus and the occurrence of AVN; similar findings were reported by Sibiński et al⁷ who reviewed 103 DDH hips (n = 77) and could not find any significant association between the size of the ossific nucleus and AVN. Thus, in clinical practice we do not recommend delaying treatment until the appearance of the ossific nucleus. Our current study showed that the occurrence of AVN negatively correlates with the diameter of femoral head and age at reduction. In particular, although the diameter of the femoral head negatively correlates with the severity of the dislocation according to the Tönnis grading system, subgroup analysis found that incidence of AVN negatively correlates with the size (diameter) of the femoral head in both Tönnis grades I to II and III to IV dislocations. Results of previous studies about the effect of age on AVN remain controversial. Most studies reported that the occurrence of AVN did not increase with age. Schur et al,¹² Sankar et al,³ Gregosiewicz and Wośko,³⁵ Brougham et al³⁶ and Cha et al³⁷ reported that there was no significant difference in the incidence of AVN among different ages, and concluded age was not a risk factor for AVN. However, many other studies showed contradictory results. Sibiński et al,⁷ Weiner et al¹⁰ and Kruczynski³⁸ found that the incidence of AVN increased and the severity decreased with age. Schur et al¹² and Kalamchi and MacEwen¹⁸ noted that the severe forms of AVN decreased with age, especially in patients older than six months when treated. Our findings indicate that the rate of AVN decreases with age, maybe due to increased number and size of vessels to the proximal femoral epiphysis in older children.^39–42

Table 6

Previous studies having evaluated the correlation between ossific nucleus and avascular necrosis (AVN)

				Ossific nucleus present		Ossific nucleus absent		Yes/no related
Author	Year	Journal	AVN, %	AVN, n (%)	Total	AVN, n (%)	Total
Current study	2020	J Child Orthop	16.9	16 (15.2)	105	5 (26.3)	19	No
Segal et al⁸	1999	J Pediatr Orthop	35.1	1 (6.3)	16	12 (57.1)	21	Yes
Carney et al²⁹	2004	J Surg Orthop Adv	35.4	4 (17.4)	23	13 (52.0)	25	Yes
Clarke et al³⁰	2005	J Pediatr Orthop	21.7	5 (25.0)	20	0 (0.0)	3	Yes
Cooke et al¹³	2010	J Pediatr Orthop B	6.3	1 (4.3)	23	2 (8.3)	24	No
Luhmann et al³¹	2003	J Bone Joint Surg [Am]	2.7	1 (1.6)	64	2 (4.2)	48	No
Roposch et al¹⁵	2009	J Bone Joint Surg [Am]	27.7	10 (24.3)	41	8 (33.3)	24	No
Sibiński et al⁷	2009	Ortop Traumatol Rehabil	32.9	37 (29.1)	127	14 (50.0)	28	No
Sllamniku et al³⁴	2013	J Child Orthop	6.8	12 (14.3)	84	4 (2.7)	150	No

It should be noted that there are still some limitations in the present study: this is a retrospective study and the follow-up time (24 to 63 months) is relatively short. However, follow-up time is enough to make sure as to whether AVN has occurred or not, as reported by previously published studies.^1,5,6,16 The correlation coefficient between the size of femoral head and incidence of AVN is relatively weak (r = -0.287); therefore, further studies with larger number of patients are needed to evaluate the effects of the size of femoral head on the incidence of AVN.

Conclusion

The size of both the femoral head and the ossific nucleus increase with age although the dislocated femoral head is smaller compared with the contralateral side. The diameter of the femoral head negatively correlates with the severity of the dislocation. Similarly, the diameter of the femoral head and not the size of the ossific nucleus negatively correlates with the risk of AVN, with bigger femoral heads showing lower risk of AVN.

Footnotes

Funding statement No benefits in any form have been received or will be received from a commercial party related directly or indirectly to the subject of this article.

Ethical statementEthical approval: Approval from our institutional review board was obtained for this retrospective study. All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed consent: Formal consent was required before all the treatment.

ICMJE Conflict of interest statement None declared.

Author Contributions WJ: Study design, Performed measurements, Manuscript preparation.

YZ: Study design, Performed measurements, Manuscript preparation.

LJ: Study design, Statistical analysis, Manuscript preparation.

ZM: Performed measurements, Manuscript preparation.

FC: Performed measurements, Manuscript preparation.

XF: Study design, Statistical analysis.

LY: Performed measurements.

XH: Study design, Manuscript modification.

References

, Zhou

, Liu

, . Closed reduction and dynamic cast immobilization in patients with developmental dysplasia of the hip between 6 and 24 months of age. Eur J Orthop Surg Traumatol 2019; 29: 51–57.

Cai

, Li

, Zhang

, Ji

, Zhao

. Dynamic long leg casting fixation for treating 12- to 18-month-old infants with developmental dysplasia of the hip. J Int Med Res 2017; 45: 272–281.

Sankar

, Gornitzky

, Clarke

NMP

, . Closed reduction for developmental dysplasia of the hip: early-term results from a prospective, multicenter cohort. J Pediatr Orthop 2019; 39: 111–118.

Sucato

, De La Rocha

, Lau

, Ramo

. Overhead Bryant's traction does not improve the success of closed reduction or limit AVN in developmental dysplasia of the hip. J Pediatr Orthop 2017; 37: e108–e113.

, Li

, Guo

, . Traction does not decrease failure of reduction and femoral head avascular necrosis in patients aged 6-24 months with developmental dysplasia of the hip treated by closed reduction: a review of 385 patients and meta-analysis. J Pediatr Orthop B 2019; 28: 436–441.

, Guo

, Shen

, . Radiographic outcome of children older than twenty-four months with developmental dysplasia of the hip treated by closed reduction and spica cast immobilization in human position: a review of fifty-one hips. Int Orthop 2019; 43: 1405–1411.

Sibiński

, Synder

, Domzalski

, Grzegorzewski

. Risk factors for avascular necrosis after closed hip reduction in developmental dysplasia of the hip. Ortop Traumatol Rehabil 2004; 6: 60–66.

Segal

, Boal

, Borthwick

, . Avascular necrosis after treatment of DDH: the protective influence of the ossific nucleus. J Pediatr Orthop 1999; 19: 177–184.

Dimeglio

, Kaelin

, Bonnel

, . The growing hip: specifications and requirements. J Pediatr Orthop 1994; 3: 135–147.

10.

Weiner

, Hoyt

Jr , O'dell

. Congenital dislocation of the hip. The relationship of premanipulation traction and age to avascular necrosis of the femoral head. J Bone Joint Surg [Am] 1977; 59-A: 306–311.

11.

Chen

, Doyle

, Green

, . Presence of the ossific nucleus and risk of osteonecrosis in the treatment of developmental dysplasia of the hip: a meta-analysis of cohort and case-control studies. J Bone Joint Surg [Am] 2017; 99: 760–767.

12.

Schur

, Lee

, Arkader

, Catalano

, Choi

. Risk factors for avascular necrosis after closed reduction for developmental dysplasia of the hip. J Child Orthop 2016; 10: 185–192.

13.

Cooke

, Rees

, Edwards

, Kiely

, Evans

. Ossification of the femoral head at closed reduction for developmental dysplasia of the hip and its influence on the long-term outcome. J Pediatr Orthop B 2010; 19: 22–26.

14.

Niziol

, Elvey

, Protopapa

, Roposch

. Association between the ossific nucleus and osteonecrosis in treating developmental dysplasia of the Hip: updated meta-analysis. BMC Musculoskelet Disord 2017; 18: 165.

15.

Roposch

, Stöhr

, Dobson

. The effect of the femoral head ossific nucleus in the treatment of developmental dysplasia of the hip. A meta-analysis. J Bone Joint Surg [Am] 2009; 91-A: 911–918.

16.

, Guo

, Li

, . Acetabular index is the best predictor of late residual acetabular dysplasia after closed reduction in developmental dysplasia of the hip. Int Orthop 2018; 42: 631–640.

17.

Tönnis

. Development of the hip joint. In: Tönnis

, ed. Congenital dysplasia and dislocation of the hip in children and adults. Berlin, Heidelberg: Springer-Verlag, 1987: 13–22.

18.

Kalamchi

, MacEwen

. Avascular necrosis following treatment of congenital dislocation of the hip. J Bone Joint Surg [Am] 1980; 62-A: 876–888.

19.

Gage

, Winter

. Avascular necrosis of the capital femoral epiphysis as a complication of closed reduction of congenital dislocation of the hip. A critical review of twenty years’ experience at Gillette Children's Hospital. J Bone Joint Surg [Am] 1972; 54-A: 373–388.

20.

Severin

. Contribution to the knowledge of congenital dislocation of the hip joint. Acta Chir Scand 1941; 84 (suppl 63): 1–142.

21.

Wanner

, Loder

, Jennings

, Ouyang

, Karmazyn B. Changes in femoral head size and growth rate in young children with severe developmental dysplasia of the hip. Pediatr Radiol 2017; 47: 1787–1792.

22.

O'Brien

, Salter

. Femoral head size in congenital dislocation of the hip. J Pediatr Orthop 1985; 5: 299–301.

23.

Sugano

, Noble

, Kamaric

, . The morphology of the femur in developmental dysplasia of the hip. J Bone Joint Surg [Br] 1998; 80-B: 711–719.

24.

Crowe

, Mani

, Ranawat

. Total hip replacement in congenital dislocation and dysplasia of the hip. J Bone Joint Surg [Am] 1979; 61-A: 15–23.

25.

Sankar

, Neubuerger

, Moseley

. Femoral head sphericity in untreated developmental dislocation of the hip. J Pediatr Orthop 2010; 30: 558–561.

26.

Wells

, Nepple

, Crook

, . Femoral morphology in the dysplastic hip: three-dimensional characterizations with CT. Clin Orthop Relat Res 2017; 475: 1045–1054.

27.

Steppacher

, Tannast

, Werlen

, Siebenrock

. Femoral morphology differs between deficient and excessive acetabular coverage. Clin Orthop Relat Res 2008; 466: 782–790.

28.

Clohisy

, Nunley

, Carlisle

, Schoenecker

. Incidence and characteristics of femoral deformities in the dysplastic hip. Clin Orthop Relat Res 2009; 467: 128–134.

29.

Carney

, Clark

, Minter

. Is the absence of the ossific nucleus prognostic for avascular necrosis after closed reduction of developmental dysplasia of the hip? J Surg Orthop Adv 2004; 13: 24–29.

30.

Clarke

NMP

, Jowett

AJL

, Parker

. The surgical treatment of established congenital dislocation of the hip: results of surgery after planned delayed intervention following the appearance of the capital femoral ossific nucleus. J Pediatr Orthop 2005; 25: 434–439.

31.

Luhmann

, Schoenecker

, Anderson

, Bassett

. The prognostic importance of the ossific nucleus in the treatment of congenital dysplasia of the hip. J Bone Joint Surg [Am] 1998; 80-A: 1719–1727.

32.

Clarke

NMP

. Blood supply and proximal femoral epiphyseal deformity in congenital dislocation of the hip. In: Uhthoff

, Wiley

, eds. Behavior of the growth plate. New York; Raven Press, 1988: 371–378.

33.

Wilkinson

. Congenital displacement of the hip joint. Berlin; Springer-Verlag, 1985: 39–42.

34.

Sllamniku

, Bytyqi

, Murtezani

, Haxhija

. Correlation between avascular necrosis and the presence of the ossific nucleus when treating developmental dysplasia of the hip. J Child Orthop 2013; 7: 501–505.

35.

Gregosiewicz

, Wośko

. Risk factors of avascular necrosis in the treatment of congenital dislocation of the hip. J Pediatr Orthop 1988; 8: 17–19.

36.

Brougham

, Broughton

, Cole

, Menelaus

. Avascular necrosis following closed reduction of congenital dislocation of the hip. Review of influencing factors and long-term follow-up. J Bone Joint Surg [Br] 1990; 72-B: 557–562.

37.

Cha

, Shin

. Long-term results of closed reduction for developmental dislocation of the hip in children of walking age under eighteen months old. Int Orthop 2018; 42: 175–182.

38.

Kruczynski

. Avascular necrosis of the proximal femur in developmental dislocation of the hip. Incidence, risk factors, sequelae and MR imaging for diagnosis and prognosis. Acta Orthop Scand Suppl 1996; 268: 1–48.

39.

Trueta

. The normal vascular anatomy of the human femoral head during growth. J Bone Joint Surg [Br] 1957; 39-B: 358–394.

40.

Wolcott

. The evolution of the circulation in the developing femoral head and neck. Surg Gynecol Obstet 1943; 77: 185.

41.

Tucker

. Arterial supply to the femoral head and its clinical importance. J Bone Joint Surg [Br] 1949; 31-B: 82–93.

42.

Wang

, Wang

, Xiao

, . Cyclic compressive stress-induced scinderin regulates progress of developmental dysplasia of the hip. Biochem Biophys Res Commun 2017; 485: 400–408.

Does the size of the femoral head correlate with the incidence of avascular necrosis of the proximal femoral epiphysis in children with developmental dysplasia of the hip treated by closed reduction?

Abstract

Abstract

Purpose

Methods

Results

Conclusions

Level of evidence

Keywords

Introduction

Materials and methods

Radiographic assessment

Ossific nucleus and size of the proximal femoral epiphysis

Statistical analysis

Results

Discussion

Conclusion

Footnotes

References